USE OF AGOMELATINE TO OBTAIN A MEDICATION AIMED AT TREATING GENERALISED ANXIETY DISORDER

    公开(公告)号:RS51485B

    公开(公告)日:2011-04-30

    申请号:RSP20100497

    申请日:2007-04-06

    Applicant: SERVIER LAB

    Abstract: Use of agomelatine or N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide or its hydrates, crystalline forms and acid/base additive salts, to obtain a drug for the treatment of generalized anxiety disorders. An independent claim is included for a composition comprising agomelatine, optionally in combination with excipients, for the manufacture of a drug to treat generalized anxiety disorders. ACTIVITY : Tranquilizer; Antidepressant; Hypnotic; Cardiovascular-Gen; Gastrointestinal-Gen; Anorectic. MECHANISM OF ACTION : Melatoninergic system receptors agonist; 5-HT2c receptor antagonist.

Patent Agency Ranking